Identifying critically ill patients at risk of death from coronavirus disease

doi:10.5847/wjem.j.1920-8642.2021.01.003

Abstract

Abstract:

BACKGROUND: A pandemic of coronavirus disease (COVID-19) has been declared by the World Health Organization (WHO) and caring for critically ill patients is expected to be at the core of battling this disease. However, little is known regarding an early detection of patients at high risk of fatality.

METHODS: This retrospective cohort study recruited consecutive adult patients admitted between February 8 and February 29, 2020, to the three intensive care units (ICUs) in a designated hospital for treating COVID-19 in Wuhan. The detailed clinical information and laboratory results for each patient were obtained. The primary outcome was in-hospital mortality. Potential predictors were analyzed for possible association with outcomes, and the predictive performance of indicators was assessed from the receiver operating characteristic (ROC) curve.

RESULTS: A total of 121 critically ill patients were included in the study, and 28.9% (35/121) of them died in the hospital. The non-survivors were older and more likely to develop acute organ dysfunction, and had higher Sequential Organ Failure Assessment (SOFA) and quick SOFA (qSOFA) scores. Among the laboratory variables on admission, we identified 12 useful biomarkers for the prediction of in-hospital mortality, as suggested by area under the curve (AUC) above 0.80. The AUCs for three markers neutrophil-to-lymphocyte ratio (NLR), thyroid hormones free triiodothyronine (FT3), and ferritin were 0.857, 0.863, and 0.827, respectively. The combination of two easily accessed variables NLR and ferritin had comparable AUC with SOFA score for the prediction of in-hospital mortality (0.901 vs. 0.955, P=0.085).

CONCLUSIONS: Acute organ dysfunction combined with older age is associated with fatal outcomes in COVID-19 patients. Circulating biomarkers could be used as powerful predictors for the in-hospital mortality.

Key words: Coronavirus disease, Neutrophil-to-lymphocyte ratio, Mortality, Predictor

Wei Guo, Lin-yu Ran, Ji-hong Zhu, Qing-gang Ge, Zhe Du, Fei-long Wang, Wei-bo Gao, Tian-bing Wang. Identifying critically ill patients at risk of death from coronavirus disease[J]. World Journal of Emergency Medicine, 2021, 12(1): 18-23.

Figures/Tables 2

Table 1

Performance of variables for predicting in-hospital mortality in COVID-19 patients*

Variables	AUC	95% CI	Cut-off value	Sensitivity (%)	Specificity (%)	P
SOFA	0.960	0.908-0.987	2	94.29	93.02	<0.001
Free triiodothyronine	0.863	0.761-0.932	3.25 pmol/L	94.44	75.93	<0.001
Neutrophil-to-lymphocyte ratio	0.857	0.782-0.914	8.48	85.71	79.07	<0.001
Procalcitonin	0.850	0.771-0.910	0.38 ng/mL	84.85	76.54	<0.001
Neutrophil count	0.842	0.764-0.902	5.71×10⁹/L	82.86	77.91	<0.001
Prothrombin time	0.828	0.748-0.891	15.2 seconds	71.43	85.88	<0.001
White blood cell count	0.827	0.747-0.889	7.04×10⁹/L	85.71	70.93	<0.001
Ferritin	0.827	0.744-0.892	862.7 μg/L	94.12	58.44	<0.001
Direct bilirubin	0.826	0.746-0.889	5.2 μmol/L	80.00	74.12	<0.001
High sensitive C-reactive protein	0.824	0.742-0.889	131.1 mg/L	68.57	85.00	<0.001
Albumin	0.811	0.730-0.877	31.9 g/L	94.29	61.63	<0.001
High sensitive troponin I	0.808	0.722-0.877	33.4 ng/mL	73.53	86.84	<0.001
Total bilirubin	0.794	0.711-0.862	10.1 μmol/L	85.71	61.63	<0.001
Lactate dehydrogenase	0.794	0.710-0.862	425 U/L	77.14	76.74	<0.001
NT-proBNP	0.793	0.704-0.864	247 pg/mL	96.97	56.58	<0.001
Creatine kinase muscle brain isoenzyme	0.793	0.695-0.870	2.2 ng/mL	70.37	87.69	<0.001
Fibrin degradation products	0.792	0.701-0.866	8.9 μg/mL	81.25	69.01	<0.001
D-dimer	0.786	0.702-0.856	2.21 μg/mL	80.00	68.24	<0.001
Aspartate aminotransferase	0.763	0.677-0.836	33 U/L	88.57	60.47	<0.001
Blood urea nitrogen	0.761	0.675-0.834	5.2 μmol/L	91.43	56.98	<0.001
Lymphocyte count	0.734	0.646-0.811	0.65×10⁹/L	68.57	74.42	<0.001
qSOFA	0.734	0.646-0.810	0	97.14	32.56	<0.001
Myohemoglobin	0.726	0.622-0.814	87 ng/mL	77.78	60.94	<0.001
Interleukin-2 receptor	0.720	0.627-0.802	1,215 U/mL	73.53	64.47	<0.001
Glucose	0.717	0.626-0.797	6.39 mmol/L	77.14	65.43	<0.001
AT3	0.710	0.611-0.796	78%	45.16	87.14	<0.001
Free thyroxine	0.693	0.573-0.796	19.35 pmol/L	83.33	55.56	0.003
Alanine aminotransferase	0.677	0.586-0.759	50 U/L	42.86	88.37	0.001
Creatine kinase	0.664	0.569-0.750	207 U/L	53.57	84.88	0.012
Platelet count	0.650	0.558-0.734	239×10⁹/L	85.71	44.19	0.008
Age	0.626	0.534-0.712	56	88.57	31.40	0.021

Table 1

Figure 1.

References 30

1	Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020; 382(8):727-33. doi: 10.1056/NEJMoa2001017 pmid: 31978945
2	Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323(11):1061-9. doi: 10.1001/jama.2020.1585 pmid: 32031570
3	Chang D, Lin M, Wei L, Xie L, Zhu G, Cruz CS, et al. Epidemiologic and clinical characteristics of novel coronavirus infections involving 13 patients outside Wuhan, China. JAMA. 2020; 323(11):1092-3. doi: 10.1001/jama.2020.1623 pmid: 32031568
4	Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First case of 2019 novel coronavirus in the United States. N Engl J Med. 2020; 382(10):929-36. doi: 10.1056/NEJMoa2001191 pmid: 32004427
5	Allione A, Giamello JD, Bernardi S, Paglietta G, Cavalot GLM, Dutto LA, et al. Coronavirus disease 2019 (COVID-19) and prosthetic heart valve: An additional coagulative challenge. World J Emerg Med. 2020; 11(4):258-9. doi: 10.5847/wjem.j.1920-8642.2020.04.009 pmid: 33014223
6	WHO. Coronavirus disease 2019 (COVID-19) situation report - 55. March 15, 2020. https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200315-sitrep-55-covid-19.pdf?sfvrsn=33daa5cb_6. Accessed March 16, 2020.
7	Levy MM, Evans LE, Rhodes A. The surviving sepsis campaign bundle: 2018 update. Intensive Care Med. 2018; 44(6):925-8. pmid: 29675566
8	Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5 pmid: 31986264
9	Force AD, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E. Acute respiratory distress syndrome. JAMA. 2012; 307(23):2526-33. doi: 10.1001/jama.2012.5669 pmid: 22797452
10	Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120(4):c179-84. pmid: 22890468
11	Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016; 18(8):891-975.
12	Seymour CW, Liu VX, Iwashyna TJ, Brunkhorst FM, Rea TD, Scherag A, et al. Assessment of clinical criteria for sepsis: for the third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016; 315(8):762-74. doi: 10.1001/jama.2016.0288 pmid: 26903335
13	Mackinnon A, Mulligan R. Combining cognitive testing and informant report to increase accuracy in screening for dementia. Am J Psychiatry. 1998; 155(11):1529-35. pmid: 9812113
14	Hanley JA, McNeil BJ. A method of comparing the areas under ROC curves derived from same cases. Radiology. 1983; 148(3):839-43. pmid: 6878708
15	Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395(10229):1054-62. pmid: 32171076
16	Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020; 8(5):475-81. pmid: 32105632
17	Faria SS, Fernandes Jr PC, Silva MJ, Lima VC, Fontes W, Freitas-Junior R, et al. The neutrophil-to-lymphocyte ratio: a narrative review. Ecancermedicalscience. 2016; 10:702. doi: 10.3332/ecancer.2016.702 pmid: 28105073
18	Templeton AJ, McNamara MG, Šeruga B, Vera-Badillo FE, Aneja P, Ocaña A, et al. Prognostic role of neutrophil-to-lymphocyte ratio in solid tumors: a systematic review and meta-analysis. J Natl Cancer Inst. 2014; 106(6):dju124. doi: 10.1093/jnci/dju124 pmid: 24875653
19	Bhat T, Teli S, Rijal J, Bhat H, Raza M, Khoueiry G, et al. Neutrophil to lymphocyte ratio and cardiovascular diseases: a review. Expert Rev Cardiovasc Ther. 2013; 11(1):55-9. pmid: 23259445
20	Hwang SY, Shin TG, Jo IJ, Jeon K, Suh GY, Lee TR, et al. Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patients. Am J Emerg Med. 2017; 35(2):234-9. doi: 10.1016/j.ajem.2016.10.055 pmid: 27806894
21	Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev. 2009; 23(3):95-104. pmid: 18835072
22	Kell DB, Pretorius E. Serum ferritin is an important inflammatory disease marker, as it is mainly a leakage product from damaged cells. Metallomics. 2014; 6(4):748-73. doi: 10.1039/c3mt00347g pmid: 24549403
23	Rosário C, Zandman-Goddard G, Meyron-Holtz EG, D’Cruz DP, Shoenfeld Y. The hyperferritinemic syndrome: macrophage activation syndrome, Still’s disease, septic shock and catastrophic antiphospholipid syndrome. BMC Med. 2013; 11(1):185.
24	Cohen LA, Gutierrez L, Weiss A, Leichtmann-Bardoogo Y, Zhang DL, Crooks DR, et al. Serum ferritin is derived primarily from macrophages through a nonclassical secretory pathway. Blood. 2010; 116(9):1574-84. doi: 10.1182/blood-2009-11-253815 pmid: 20472835
25	Lalueza A, Ayuso B, Arrieta E, Trujillo H, Folgueira D, Cueto C, et al. Elevation of serum ferritin levels for predicting a poor outcome in hospitalized patients with influenza infection. Clin Microbiol Infect. 2020; 26(11):1557.e9-1557.e15.
26	van den Berghe G. The neuroendocrine response to stress is a dynamic process. Best Pract Res Clin Endocrinol Metab. 2001; 15(4):405-19. pmid: 11800514
27	Wang F, Pan W, Wang H, Wang S, Pan S, Ge J. Relationship between thyroid function and ICU mortality: a prospective observation study. Crit Care. 2012; 16(1):R11. doi: 10.1186/cc11151 pmid: 22257427
28	Warner MH, Beckett GJ. Mechanisms behind the non-thyroidal illness syndrome: an update. J Endocrinol. 2010; 205(1):1-3. pmid: 20016054
29	Tisoncik JR, Korth MJ, Simmons CP, Farrar J, Martin TR, Katze MG. Into the eye of the cytokine storm. Microbiol Mol Biol Rev. 2012; 76(1):16-32. doi: 10.1128/MMBR.05015-11 pmid: 22390970
30	Mehta P McAuley DF Brown M Sanchez M Tattersall RS Manson JJ, COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 ; 395(10229):1033-4. doi: 10.1016/S0140-6736(20)30628-0 pmid: 32192578

[1]	Ahammed Mekkodathil, Ayman El-Menyar, Talat Chughtai, Ahmed Abdel-Aziz Bahey, Ahmed Labib Shehatta, Ali Ayyad, Abdulnasser Alyafai, Hassan Al-Thani. Initial serum electrolyte imbalances and mortality in patients with traumatic brain injury: a retrospective study [J]. World Journal of Emergency Medicine, 2025, 16(4): 331-339.
[2]	Carlos del Pozo Vegas, Ancor Sanz-García, Antonio Dueñas-Ruiz, Pedro de Santos Castro, Ana Gil Contreras, María Blanco González, Alberto Correas Galán, Joan B. Soriano, Raúl López-Izquierdo, Francisco Martín-Rodríguez. Prehospital oxygen-therapy and mortality in patients treated by emergency medical services: a prospective, observational multicenter study [J]. World Journal of Emergency Medicine, 2025, 16(4): 357-366.
[3]	Jesús Jurado-Palomo, José Luis Martín-Conty, Begoña Polonio-López, Cristina Rivera Picón, Raúl López-Izquierdo, Carlos del Pozo Vegas, Pedro Ángel de Santos Castro, Ancor Sanz-García, Francisco Martín-Rodríguez. Prehospital critical care drug-therapy and 30-day mortality in patients with acute respiratory disease [J]. World Journal of Emergency Medicine, 2025, 16(1): 43-50.
[4]	Chao Gong, Shengyong Xu, Youlong Pan, Shigong Guo, Joseph Harold Walline, Xue Wang, Xin Lu, Shiyuan Yu, Mubing Qin, Huadong Zhu, Yanxia Gao, Yi Li. Effects of probiotic treatment on the prognosis of patients with sepsis: a systematic review [J]. World Journal of Emergency Medicine, 2025, 16(1): 18-27.
[5]	Xinlei Wang, Yao Sun, Xiaoyu Ni, Shu Zhang. Development and validation of an emergency bloodstream infection score for predicting in-hospital mortality in patients with community-acquired bloodstream infections [J]. World Journal of Emergency Medicine, 2023, 14(4): 280-286.
[6]	Hai Hu, Ni Yao, Xiao-qin Lai. Factors related to early and rapid assessment of in-hospital mortality among older adult trauma patients in an earthquake [J]. World Journal of Emergency Medicine, 2022, 13(6): 425-432.
[7]	Ralph Bou Chebl, Nadim Kattouf, Mohamad Assaf, Saadeddine Haidar, Gilbert Abou Dagher, Sarah Abdul Nabi, Rana Bachir, Mazen El Sayed. Comparing the demographic data and outcomes of septic shock patients presenting to teaching or non-teaching metropolitan hospitals in the United States [J]. World Journal of Emergency Medicine, 2022, 13(6): 433-440.
[8]	Gui-ying Dong, Fei-fei Jin, Qi Huang, Chun-bo Wu, Ji-hong Zhu, Tian-bing Wang. Exploratory COVID-19 death risk score based on basic laboratory tests and physiological clinical measurements [J]. World Journal of Emergency Medicine, 2022, 13(6): 453-458.
[9]	Chun Zhao, Mei-yun Xin, Jing Li, Jin-fang Zhao, Yu-juan Wang, Wei Wang, Qian Gao, Jie Chen, Qi-wei Wang, You-peng Jin. Comparing the precision of the pSOFA and SIRS scores in predicting sepsis-related deaths among hospitalized children: a multi-center retrospective cohort study [J]. World Journal of Emergency Medicine, 2022, 13(4): 259-265.
[10]	Hai Hu, Jing-yuan Jiang, Ni Yao. Comparison of different versions of the quick sequential organ failure assessment for predicting in-hospital mortality of sepsis patients: A retrospective observational study [J]. World Journal of Emergency Medicine, 2022, 13(2): 114-119.
[11]	Wen-qiang Jiang, Xu-sheng Li, Wen-hong Zhong, Lin-qiang Huang, Xiao-jun Lin, Miao-yun Wen, Yu-jun Deng, Xin Li, Hong-ke Zeng. Comparison of clinical characteristics in patients with coronavirus disease and influenza A in Guangzhou, China [J]. World Journal of Emergency Medicine, 2021, 12(4): 287-292.
[12]	Ren-qi Yao, Chao Ren, Di Ren, Jin-xiu Li, Ying Li, Xue-yan Liu, Lei Huang, Yong Liu, Mian Peng, Yong-wen Feng, Yong-ming Yao. Development of septic shock and prognostic assessment in critically ill patients with coronavirus disease outside Wuhan, China [J]. World Journal of Emergency Medicine, 2021, 12(4): 293-298.
[13]	Gui-long Feng, Miao-miao Zheng, Shi-hong Yao, Yin-qi Li, Shao-jun Zhang, Wei-jing Wen, Kai Fan, Jia-li Zhang, Xiao Zhang. Risk factors and predictive model of adrenocortical insufficiency in patients with traumatic brain injury [J]. World Journal of Emergency Medicine, 2021, 12(3): 179-184.
[14]	Yu-qing Cui, Xian-fei Ding, Huo-yan Liang, Dong Wang, Xiao-juan Zhang, Li-feng Li, Quan-cheng Kan, Le-xin Wang, Tong-wen Sun. Efficacy and safety of low-dose corticosteroids for acute respiratory distress syndrome: A systematic review and meta-analysis [J]. World Journal of Emergency Medicine, 2021, 12(3): 207-213.
[15]	Wen Gao, Yu-ping Zhang, Jing-fen Jin. Poor outcomes of delirium in the intensive care units are amplified by increasing age: A retrospective cohort study [J]. World Journal of Emergency Medicine, 2021, 12(2): 117-123.